Region
Featured experience
Atairos investment in the parent company of the Aston Villa Football Club
We are advising Atairos on the minority investment
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
$100 million investment by consortium in Airbus subsidiary AALTO
We are advising Airbus on the transaction
Haleon $3 billion secondary placing of ordinary shares
The private placement included 700,000,000 ordinary shares
CRH $2.5 billion guaranteed notes offering
The investment-grade notes are due 2031, 2036 and 2056
Over $44 billion of structured credit financings year to date
We advised on 119 structured credit transactions in the first three quarters of 2025
CoreWeave acquisition of Monolith AI
We are advising CoreWeave on the transaction
Amulet Capital Partners sale of SSI Strategy to Clinigen
We are advising Amulet Capital Partners and SSI Strategy on the sale
Medtronic €1.5 billion notes offering
The investment-grade notes are due 2030 and 2045
Ferguson $750 million senior notes offering
The investment-grade notes are due 2031
Heineken $3.2 billion acquisition of FIFCO beverage and retail businesses
We are advising Heineken on the transaction
British American Tobacco $750 million notes offering
The investment-grade notes are due 2033
Natura sale of Avon International to Regent
We are advising Natura on the sale
Royalty Pharma $2 billion senior notes offering
We advised Royalty Pharma on its investment-grade notes offering